Legal Representation
Attorney
David M. Tener, Esq.
USPTO Deadlines
Next Deadline
1822 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241224)
Due Date
December 24, 2030
Grace Period Ends
June 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 24, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 24, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 3, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Dec 3, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Dec 2, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 21, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 21, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 18, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jul 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 18, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 21, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 18, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| May 22, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jun 28, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 24, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 24, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 24, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 2, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 2, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 27, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Nov 21, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 26, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 26, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 6, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 21, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 15, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 14, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 15, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 15, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Feb 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 14, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 14, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 7, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 26, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 23, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Chemical preparations for medical use for research and for genetic diagnostics, namely, for the discovery, development and delivery of cell and gene therapies for treating genetic diseases; Diagnostic agents for medical use for research and for genetic diagnostics; Reagents for medical use for research and for genetic diagnostics; Chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; Medicines for the treatment of genetic diseases
First Use Anywhere:
20240500
First Use in Commerce:
20240500
Class 042
Analyses in the field of molecular biology; Analysis of the chemical composition of liquids; Chemical analysis; Chemical and biochemical analyses; Chemical engineering services; Chemical laboratory services; Chemical research; Chemical technology research; Computer-aided scientific testing of DNA samples for diagnostic purposes; Scientific research in the nature of conducting clinical trials for others for pharmaceutical and genetic products; Consultancy in the field of pharmaceutical research; Consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemicals used in the field of genetics; Development of new products in the field of gene therapy; Development of pharmaceutical preparations and medicines; Development of pharmaceutical products; Testing and evaluation of chemicals; Genetic analyses for scientific research purposes; Industrial packaging design services; Inspection of pharmaceutical products; Laboratory research in the field of genetics; Laboratory research services concerning pharmaceutical products; Pharmaceutical product development services; Pharmaceutical research services; Provision of information concerning the results of clinical trials for pharmaceutical products; Quality evaluation of pharmaceutical products; Research and development for the pharmaceutical industry; Research and development of new products for third parties; Research in the field of pharmaceutical products; Scientific analyses and research in the field of transfection; Scientific development of transfection agents; Scientific research for medical purposes in the field of genetics and genetic engineering; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of medicines; Scientific testing services in the field of genetics; Services of a genetic research laboratory, namely, genetic testing for scientific research purposes and development of gene therapies for medical purposes; Software design and computer software design in the field of scientific research and genetic analyses; Structural and functional analysis of genomes; Testing of chemical products; Testing on pharmaceutical products
First Use Anywhere:
20240500
First Use in Commerce:
20240500
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"